BioMAX is the first X-ray macromolecular crystallography beamline of MAX IV Laboratory. It has been in user operation since 2017. The design goal for BioMAX was to create a stable and reliable beamline that is user friendly. The beamline experiment set-up is highly automated, in terms of both sample handling hardware and data analysis, and it can also to accommodate multiple experimental possibilities, like experimental phasing, in situ screening, and Synchrotron-based serial crystallography (SSX) experiments. Remote data collection is enabled by default. BioMAX hosts FragMAX , the MAX IV platform for fragment-based drug discovery.
| Available for | Technique description |
| General Users | Conventional rotation data collection (fixed point or helical) at a wide range of energies and variable beam size. |
| General Users | Automated sample mounting and dismounting from UniPucks, 29 puck positions in dewar. |
| General Users | Sample temperature 100 K; room temperature with or without humidity control available for manual mounting only. |
| General Users | SAD and MAD experiments. Interleaved data collection. |
| General Users | Automated data integration, scaling and merging. Offline remote access for manual data processsing. |
| General Users | SX experiments using fixed target or flow chips compatible with the MD3 minikappa. Please contact beamline manager. |
| General Users | Element identification by X-ray Fluorescence. Fast energy scans. |
| General Users | Automated data collection. Please contact beamline manager. |
| General Users | Remote data collection. |
| General Users | In-situ screening with different plate types. Please contact beamline manager. |
| General Users | Fragment-based drug screening. Please contact beamline manager. |
| Commissioning Users | Automated sample mounting and dismounting of samples in capillaries. Please contact beamline manager. |
| See also BioMAX User Information. |
Beamline documents
Macromolecular Crystallography Review Report (download PDF)
